Publication | Open Access
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
264
Citations
35
References
2016
Year
NCT01582269, ClinicalTrials.gov.
| Year | Citations | |
|---|---|---|
Page 1
Page 1